Search Results - "Chronic myelogenous leukemia"

Marine Natural Products as Anticancer Agents 2.0

Subjects: “…chronic myelogenous leukemia…”
DOAB: download the publication
DOAB: description of the publication

Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML Patients by Hamza MS, Shouman SA, Abdelfattah R, Moussa HS, Omran MM

Connect to this object online.

Synthesis and identification of GZD856 as an orally bioavailable Bcr-AblT315I inhibitor overcoming acquired imatinib resistance by Xiaoyun Lu, Zhang Zhang, Xiaomei Ren, Deping Wang, Ke Ding

Connect to this object online.

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States by Robert Roskoski Jr

Connect to this object online.

Case Report of a Child after Hematopoietic Cell Transplantation with Acute Aspergillus Tracheobronchitis as a Cause for Respiratory Failure by Stefanie Gauguet, Kate Madden, Jennifer Wu, Christine Duncan, Gi Soo Lee, Tonya Miller, William C. Klingensmith, Sandra K. Burchett, Meredith van der Velden

Connect to this object online.

Molecular landscape and targeted therapy of acute myeloid leukemia by Runxia Gu, Xue Yang, Hui Wei

Connect to this object online.

What About Bob? by Marshall Anderson

Connect to this object online.

Development of Asymmetric Facial Depigmentation in a Patient Treated with Dasatinib with New-Onset Hypovitaminosis D: Case Report and Review of the Literature by Kirsten C. Webb, Magdalena Harasimowicz, Monica Janeczek, Jodi Speiser, James Swan, Rebecca Tung

Connect to this object online.

Chronic Myeloid Leukemia with Rare e1a3 BCR-ABL Transcript by Najia Tabassum, Rubina Ghani, Mohammad Saboor, Moinuddin Moinuddin

Connect to this object online.

Uncommon presentation of a common histiocytic tumor: A rare entity by Chinmay Kar, Kapildev Das, Jayanta K Barua

Connect to this object online.

Xanthohumol, a Prenylated Flavonoid from Hops, Induces Caspase-Dependent Degradation of Oncoprotein BCR-ABL in K562 Cells by Xuxiu Lu, Jiajia Geng, Jinman Zhang, Jinlai Miao, Ming Liu

Connect to this object online.

Cytotoxicity and Antiproliferative Activity Assay of Clove Mistletoe (Dendrophthoe pentandra (L.) Miq.) Leaves Extracts by Vida Elsyana, Maria Bintang, Bambang Pontjo Priosoeryanto

Connect to this object online.

Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies by Sechler M, Cizmic AD, Avasarala S, Van Scoyk M, Brzezinski C, Kelley N, Bikkavilli RK, Winn RA

Connect to this object online.

Modern management of leukemoid reactions by D.V. Dobrianskyi, G.L. Gumeniuk, P.F. Dudka, I.P. Tarchenko, Т.І. Коzаr, А.V. Кuchаrskа, Т.А. Leonova

Connect to this object online.

Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro by Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D. Tselepis

Connect to this object online.

Studies on the inhibitory effect of isavuconazole on flumatinib metabolism in vitro and in vivo by Ya-nan Liu, Ya-nan Liu, Xinhao Xu, Xinhao Xu, Jingjing Nie, Jingjing Nie, Yingying Hu, Xuegu Xu, Ren-ai Xu, Xiaoxiang Du

Connect to this object online.

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update by Robert Roskoski, Jr

Connect to this object online.

A Bcr-Abl Inhibitor GNF-2 Attenuates Inflammatory Activation of Glia and Chronic Pain by Gyun Jee Song, Gyun Jee Song, Md Habibur Rahman, Mithilesh Kumar Jha, Mithilesh Kumar Jha, Deepak Prasad Gupta, Deepak Prasad Gupta, Sung Hee Park, Jae-Hong Kim, Sun-Hwa Lee, In-Kyu Lee, Taebo Sim, Taebo Sim, Yong Chul Bae, Won-Ha Lee, Kyoungho Suk

Connect to this object online.

Novel 1, 1-dimethyl-3-phenyl-3-(5-phenyl-1, 3, 4- thiadiazol-2-yl) urea derivative has potential antiproliferative activity against human leukemia cell lines - K562 by Khemkaran Ahirwar, Sanmati K. Jain, Bholenath Tamrakar

Connect to this object online.

Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a/PPFIA1 Signaling Pathway by Chunming Gu, Yanjun Liu, Zhao Yin, Juhua Yang, Guiping Huang, Xuejiao Zhu, Yumin Li, Jia Fei

Connect to this object online.